-- cannot be copied or reverse engineered
-- are forensic and offer absolute authentication
-- are "green," safe and affordable
APDN has recently been selected to launch its SigNature DNA
Anti-Counterfeiting Program for the UK and EU as the sole security platform
to spearhead a
multi-year, multi-million dollar contract.
About Crystal
Crystal is an independent research firm that provides
institutional-quality, fee-based research to small and mid-cap companies.
Crystal's unique and novel product, the EIO®, is free of investment
ratings, target prices, and forward-looking financial models. The EIO®
presents a crystal clear, detailed report on a company (public or private)
in a manner that is easily understood by the Wall Street financial
community. The EIO® details a company's product/technology/service
offerings, market size(s), key intellectual property, leadership, growth
strategy, competition, risks, financial statements, key events, and other
such fundamental information. Crystal has offices in New York City, Delray
Beach, Montréal, and Toronto. Crystal has been compensated by the Company
in cash of forty-two thousand five-hundred dollars and two-hundred thousand
Warrants/Options for its services in creating this report, for updates, and
for printing costs.
About APDN
APDN sells patented DNA security solutions to protect products, brands and
intellectual property from counterfeiting and diversion. SigNature DNA is a
botanical mark used to authenticate products in a unique manner that
essentially cannot be copied. APDN also provides BioMaterial GenoTyping™
by detecting genomic DNA in natural materials to authenticate finished
products. Both technologies protect brands and products in a wide range of
industries and provide a forensic chain of evidence that can be used to
prosecute perpetrators. To learn more, go to www.adnas.com where APDN
routinely posts all press releases.
The statements made by APDN may be forward-looking in nature and are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements describe APDN's future
plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many of which
are beyond the control of APDN. Actual results could differ materially from
those projected due to our short operating history, limited financial
resources, limited market acceptance, market competition and various other
factors detailed from time to time in APDN's SEC reports and filings,
including our Annual Report on Form 10-K, filed on December 16, 2008 and
our subsequent quarterly reports on Form 10-Q. APDN undertakes no
obligation to update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to reflect the
occurrence of unanticipated events.
Contact Information: Crystal Research Contacts: Jeffrey J. Kraws and Karen B. Goldfarb Crystal Research Associates, LLC 609-306-2274 fax: 609-395-9339 Applied DNA Sciences Contacts: INVESTOR RELATIONS: Debbie Bailey 631-444-8090 fax: 631-444-8848 MEDIA RELATIONS: Janice Meraglia 631-444-6293 FCMN Contact: Web site: http://www.ADNAS.com